Figure 6.
Change from baseline in lumbar spine BMD after multiple SC doses of denosumab. Regimens are 6, 14, and 30 mg of denosumab given every 3 months to postmenopausal women with low BMD. Symbols represent data from the literature [10] and lines represent model-fitted profiles using the integrated bone homeostasis model.